1110.00PLN+0.54%Mkt Cap: 8.52B $P/E: 21.711d ago
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Centr…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/E
Avg
P/B
Pricier
Div Yield
Lower
1M Perf
Avg
Indicators:|
Key Statistics
Company
Market Cap8.52B $
Enterprise Value8.13B $
Revenue (TTM)527.97M $
Gross Profit299.61M $
Net Income (TTM)102.12M $
Revenue/Share17.00 USD
Last Price1110.00 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees13.2K
CountryPL
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSI0031102120
Valuation
P/E (Trailing)21.71
P/E (Forward)—
PEG—
EV/EBITDA55.19
EV/Revenue15.40
P/S15.73
P/B13.32
EPS (TTM)51.18
EPS (Forward)—
52W Range
748.0084% of range1180.00
52W High1180.00 PLN
52W Low748.00 PLN
Profitability
Gross Margin57.96%
Oper. Margin26.80%
EBITDA Margin27.90%
Profit Margin19.76%
ROE17.10%
ROA13.25%
Growth
Revenue Growth8.40%
Earnings Growth-25.80%
Cash Flow & Leverage
Operating CF133.88M $
CapEx (TTM)24.91M $
FCF Margin11.83%
FCF Yield0.73%
Net Debt-178.13M $
Net Debt/EBITDA-1.21
Balance Sheet
Debt/Equity0.01
Current Ratio4.05
Quick Ratio2.76
Book Value/Sh81.25 PLN
Cash/Share23.81 PLN
Dividends
Fwd Div Rate39.04 PLN
Trail. Div Rate9.100 PLN
Div. Yield3.60%
5Y Avg Yield4.98%
Payout Ratio69.15%
Ex-Div DateJul 21, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.30.30M
Float21.02M
Insiders17.65%
Institutions14.41%
Technical
SMA 501083.48 (+2.4%)
SMA 200966.27 (+14.9%)
Beta0.41
S&P 52W Chg20.05%
Avg Vol (30d)62
Avg Vol (10d)63
Technical Indicators
RSI (14)52.8
MACD5.4577
MACD Signal9.0083
MACD Hist.-3.5506
BB Upper1140.91 PLN
BB Middle1109.00 PLN
BB Lower1077.09 PLN
BB Width5.75%
ATR (14)29.65 PLN
Vol Ratio (20d)5.22x